Page last updated: 2024-09-05

clorazepate dipotassium and zolpidem

clorazepate dipotassium has been researched along with zolpidem in 3 studies

Compound Research Comparison

Studies (clorazepate dipotassium)	Trials (clorazepate dipotassium)	Recent Studies (post-2010) (clorazepate dipotassium)	Studies (zolpidem)	Trials (zolpidem)	Recent Studies (post-2010) (zolpidem)
325	90	11	1,825	368	683

Protein Interaction Comparison

Protein	Taxonomy	zolpidem (IC50)
Gamma-aminobutyric acid receptor subunit pi	Rattus norvegicus (Norway rat)	0.048
Gamma-aminobutyric acid receptor subunit beta-1	Rattus norvegicus (Norway rat)	0.048
Translocator protein	Rattus norvegicus (Norway rat)	4.7
Gamma-aminobutyric acid receptor subunit delta	Rattus norvegicus (Norway rat)	0.048
Gamma-aminobutyric acid receptor subunit gamma-2	Rattus norvegicus (Norway rat)	0.048
Gamma-aminobutyric acid receptor subunit alpha-5	Rattus norvegicus (Norway rat)	0.048
Gamma-aminobutyric acid receptor subunit alpha-3	Rattus norvegicus (Norway rat)	0.048
Gamma-aminobutyric acid receptor subunit gamma-1	Rattus norvegicus (Norway rat)	0.048
Gamma-aminobutyric acid receptor subunit alpha-2	Rattus norvegicus (Norway rat)	0.048
Gamma-aminobutyric acid receptor subunit alpha-4	Rattus norvegicus (Norway rat)	0.048
Gamma-aminobutyric acid receptor subunit gamma-3	Rattus norvegicus (Norway rat)	0.048
Gamma-aminobutyric acid receptor subunit alpha-6	Rattus norvegicus (Norway rat)	0.048
Gamma-aminobutyric acid receptor subunit alpha-1	Rattus norvegicus (Norway rat)	0.048
Gamma-aminobutyric acid receptor subunit beta-3	Rattus norvegicus (Norway rat)	0.048
Gamma-aminobutyric acid receptor subunit beta-2	Rattus norvegicus (Norway rat)	0.048
GABA theta subunit	Rattus norvegicus (Norway rat)	0.048
Gamma-aminobutyric acid receptor subunit epsilon	Rattus norvegicus (Norway rat)	0.048

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (66.67)	18.2507
2000's	1 (33.33)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Davis, NH	1
Schmucker, P; Schön, J; Uhlig, T	1
Capasso, A; Cavallo, F; Raffa, RB	1

Trials

1 trial(s) available for clorazepate dipotassium and zolpidem

Article	Year
[Optimizing anesthesiologic premedication with reference to biopsychological theories. Exemplified by the effect of dipotassium clorazepate and zolpidem in combination with promethazine]. Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS, 1997, Volume: 32, Issue:3 Suppl Topics: Adult; Aged; Anxiety; Arousal; Clorazepate Dipotassium; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Emotions; Female; Humans; Hypnotics and Sedatives; Male; Middle Aged; Personality Assessment; Preanesthetic Medication; Promethazine; Prospective Studies; Pyridines; Zolpidem	1997

Article

Year

[Optimizing anesthesiologic premedication with reference to biopsychological theories. Exemplified by the effect of dipotassium clorazepate and zolpidem in combination with promethazine].

Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS, 1997, Volume: 32, Issue:3 Suppl

Topics: Adult; Aged; Anxiety; Arousal; Clorazepate Dipotassium; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Emotions; Female; Humans; Hypnotics and Sedatives; Male; Middle Aged; Personality Assessment; Preanesthetic Medication; Promethazine; Prospective Studies; Pyridines; Zolpidem

1997

Other Studies

2 other study(ies) available for clorazepate dipotassium and zolpidem

Article	Year
Change from zolpidem to clorazepate won't solve the patient's problem. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1997, Mar-01, Volume: 54, Issue:5 Topics: Anti-Anxiety Agents; Clorazepate Dipotassium; Drug Tolerance; Humans; Hypnotics and Sedatives; Pyridines; Substance-Related Disorders; Zolpidem	1997
Flumazenil-sensitive dose-related physical dependence in planarians produced by two benzodiazepine and one non-benzodiazepine benzodiazepine-receptor agonists. European journal of pharmacology, 2007, Jun-14, Volume: 564, Issue:1-3 Topics: Analysis of Variance; Animals; Benzodiazepines; Clorazepate Dipotassium; Dose-Response Relationship, Drug; Flumazenil; GABA Agonists; GABA Modulators; Locomotion; Midazolam; Planarians; Pyridines; Receptors, GABA-A; Reproducibility of Results; Substance Withdrawal Syndrome; Substance-Related Disorders; Zolpidem	2007

Article

Year

Change from zolpidem to clorazepate won't solve the patient's problem.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1997, Mar-01, Volume: 54, Issue:5

Topics: Anti-Anxiety Agents; Clorazepate Dipotassium; Drug Tolerance; Humans; Hypnotics and Sedatives; Pyridines; Substance-Related Disorders; Zolpidem

1997

Flumazenil-sensitive dose-related physical dependence in planarians produced by two benzodiazepine and one non-benzodiazepine benzodiazepine-receptor agonists.

European journal of pharmacology, 2007, Jun-14, Volume: 564, Issue:1-3

Topics: Analysis of Variance; Animals; Benzodiazepines; Clorazepate Dipotassium; Dose-Response Relationship, Drug; Flumazenil; GABA Agonists; GABA Modulators; Locomotion; Midazolam; Planarians; Pyridines; Receptors, GABA-A; Reproducibility of Results; Substance Withdrawal Syndrome; Substance-Related Disorders; Zolpidem

2007